“…First, predators such as Bdellovibrio and Micavibrio have the ability to kill human Gram-negative pathogens such as Acinetobacter , Aeromonas , Bordetella , Burkholderia , Citrobacter , Enterobacter , Escherichia , Klebsiella , Listonella , Morganella , Proteus , Salmonella , Serratia , Shigella , Vibrio , Yersinia , Helicobacter pylori, and Legionella that have acquired, or are at risk of acquiring, resistance to antibiotics [86] , [90] , [91] , [92] , [93] , [94] , [95] . These predators also reduce the bacterial burden of drug-resistant members of the ESKAPE group such as K. pneumoniae , A. baumannii [86] , [96] , [97] , [98] or P. aeruginosa [99] , Stenotrophomonas maltophilia [100] and other MDRB Gram-negative clinical pathogens such as Shigella [101] .…”